https://www.selleckchem.com/products/PP242.html
These results could be therapeutically beneficial to ongoing and future pre-clinical and clinical studies involving various oxygenation agents.Coxsackievirus A6 (CV-A6) has been emerging as a major pathogen of hand, foot and mouth disease (HFMD). Study on the pathogenesis of CV-A6 infection and development of vaccines is hindered by a lack of appropriate animal models. Here, we report an actively immunized-challenged mouse model to evaluate the efficacy of a Vero-cell-based, inactivated CV-A6 vaccine candidate. The neonatal Kunming mice w
Like
Comment
Share
